Dental implant therapy has become increasingly widespread globally, with a notable rise in both the number of implants placed and the population receiving this rehabilitation. This growth has been accompanied by an increased proportion of cases with biological and mechanical complications. Among these, peri-implant inflammatory diseases—and in particular peri-implantitis, which is characterized by progressive peri-implant bone loss—have emerged as a major clinical challenge. Peri-implantitis can ultimately lead to the loss of the implant and its restoration, imposing significant financial costs and health burdens on patients.
The source article presents a case report involving severe, full-arch peri-implantitis and places that case in the context of broader clinical concerns, emphasizing that even extensive peri-implant hard and soft tissue deficiencies can be managed successfully when the right multidisciplinary and maintenance strategies are applied.
The review and case summary identify the accumulation of bacterial biofilm as the primary etiological factor for peri-implantitis. Patients with a history of unsuccessfully treated periodontal disease are more likely to develop peri-implant inflammatory conditions. The article also lists multiple additional risk factors that contribute to peri-implant disease development and progression:
These elements interact with the microbial challenge posed by biofilm to determine whether peri-implant health is maintained or whether disease processes progress.
To maximize long-term success of implant-supported restorations, the authors stress prevention and regular control. Key preventive and planning measures highlighted include:
These measures aim to reduce biofilm accumulation, improve tissue stability, and lower the risk of peri-implant inflammatory disease developing or progressing.
The article underscores that management of severe peri-implantitis—especially when it affects a full-arch implant-supported fixed bridge—requires a comprehensive, multidisciplinary approach. While specific procedural details are presented in the full case report (in the original journal), the abstract emphasizes principles that guide therapy:
The aim of these therapeutic steps is to halt disease progression, preserve implant function, and restore a maintainable peri-implant environment.
The article reports a case of severe peri-implantitis affecting a full-arch implant-supported fixed bridge. The authors report that favorable outcomes were achieved through a multidisciplinary therapeutic protocol followed by consistent maintenance. The abstract does not provide granular procedural details, patient-specific metrics, or step-by-step interventions in the summary presented on PubMed; readers are referred to the full article for procedural specifics. Nevertheless, the case is used to illustrate that even advanced peri-implant hard tissue deficiencies around full-arch reconstructions can be managed successfully when treatment is comprehensive and coordinated.
A central theme of the article is the importance of ongoing maintenance after active therapy. Prevention and regular control are described as crucial for long-term success. The case report’s long-term follow-up demonstrates that with appropriate rehabilitation and strong patient compliance to maintenance, implant function can be preserved despite compromised peri-implant hard tissue environment. The authors emphasize that consistent professional supportive therapy and patient cooperation are key to preventing recurrence and to sustaining favorable outcomes.
Key clinical takeaways from the article include:
For procedural details and the full case description, the original article in Orv Hetil (2026;167(38):1523–1531) should be consulted, as the PubMed abstract summarizes the rationale, principles, and outcomes but does not list stepwise surgical or restorative protocols in the abstract text.